newsfilter
← Latest News
GlobeNewswire·

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

VANCOUVER, British Columbia, June 10, 2026 (GLOBE NEWSWIRE) -- via IBN – Optimi Health Corp. (NASDAQ:OPTH) (CSE:OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical